Ivabradine for treating cardiogenic shock after heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if ivabradine, a drug that lowers heart rate, can help patients in cardiogenic shock after a type of heart attack called STEMI. It is for patients with a fast heart rate (at least 100 beats per minute) who cannot take beta-blockers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You had a specific type of heart attack (STEMI) that led to cardiogenic shock (your organs are not getting enough blood).
- Your heart rate is at least 100 beats per minute and you have a normal heart rhythm (sinus rhythm).
- You cannot take beta-blockers (a type of heart medication) for reasons such as needing blood pressure support or a breathing machine.
- You do not have atrial fibrillation, complete heart block, or advanced kidney disease.
- You have not had CPR for more than 12 minutes, and you are not pregnant or in another trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether giving a beta-blocker medication (metoprolol) early after a heart attack can help people who have a fast heart rate or low blood pressure but no signs of organ failure. The goal is to see if this treatment improves recovery.
This study tests whether a drug called ivabradine can safely lower a fast heart rate in people with sepsis (a severe infection that affects the whole body). It aims to see if controlling heart rate helps improve recovery.
This study tests whether ivabradine (a heart-rate medicine) can improve blood flow and other vital measurements in adults with sepsis in the ICU. It may help by lowering a fast heart rate when blood pressure is already being supported.
This trial tests whether giving a drug called ivabradine before sinus surgery helps keep your heart rate steady during the procedure. It may reduce risks during surgery for people with a normal resting heart rate.
This study tests a pill called ivabradine that lowers heart rate, to see how it affects healthy adults when they exercise. Participation requires two supervised exercise sessions.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
Hear when a new Cardiogenic Shock Post Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.